Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population
Abstract Background Low‐dose computed tomography screening has been proved to reduce lung cancer mortality, however, the issues of high false‐positive rate and overdiagnosis remain unsolved. Risk prediction models for lung cancer that could accurately identify high‐risk populations may help to incre...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wiley
2020-06-01
|
| سلاسل: | Cancer Medicine |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1002/cam4.3025 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
